SPHK1, sphingosine kinase 1, 8877

N. diseases: 236; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0856169
Disease: Endothelial dysfunction
Endothelial dysfunction
0.020 Biomarker phenotype BEFREE In summary, pharmacological inhibition of Sphk1 partially protects against Ang II-induced cardiac hypertrophy and endothelial dysfunction. 31838904 2020
CUI: C0856169
Disease: Endothelial dysfunction
Endothelial dysfunction
0.020 Biomarker phenotype BEFREE However, in our opinion, more refined strategies to target SphK1 are needed because this enzyme is protective against endothelial dysfunction and can become resistant to SphK1 inhibitors in vascular smooth muscle, thereby potentially limiting their effectiveness in PAH. 28789830 2017